Greenshoe

DIGITAL ALLY PRICES $2.9 MILLION UNDERWRITTEN PUBLIC OFFERING OF COMMON STOCK

Retrieved on: 
Friday, February 28, 2020
Finance, Financial economics, Corporate finance, Stock market, Financial markets, Initial public offering, Underwriting, Stock, Short, Public offering, Option, Greenshoe

The proposed offering equates to 2,521,740 shares of the Companys common stock at a price of $1.15 per share.

Key Points: 
  • The proposed offering equates to 2,521,740 shares of the Companys common stock at a price of $1.15 per share.
  • The Company intends to use the net proceeds from this offering to fund the repayment of debt and for general corporate purposes.
  • In addition, the Company expects to grant the underwriter a 45-day option to purchase up to an additional 15 percent of the shares of common stock offered in the public offering to cover over-allotments, if any.
  • For additional news and information please visit www.digitalallyinc.com or follow additional Digital Ally Inc. social media channels here:

Oramed Pharmaceuticals Inc. Prices Public Offering of Common Stock for Aggregate Proceeds of $21 Million

Retrieved on: 
Thursday, February 27, 2020
Financial markets, Finance, Financial economics, Stock market, Corporate finance, Equity securities, Underwriting, Stock, Shelf registration, Greenshoe, Initial public offering

Oramed has granted the underwriters a 45-day option to purchase up to 787,500 additional shares of common stock at the public offering price, less the underwriting discount.

Key Points: 
  • Oramed has granted the underwriters a 45-day option to purchase up to 787,500 additional shares of common stock at the public offering price, less the underwriting discount.
  • The offering is expected to close on or about March 2, 2020, subject to the satisfaction of customary closing conditions.
  • The gross proceeds from the offering, before deducting the underwriting discount and estimated offering expenses payable by Oramed, are expected to be $21 million.
  • The shares of common stock are being offered by Oramed pursuant to its shelf registration statement on Form S-3 (File No.

Oramed Pharmaceuticals Inc. Announces Proposed Public Offering of Common Stock

Retrieved on: 
Wednesday, February 26, 2020
Financial markets, Finance, Financial economics, Stock market, Initial public offering, Corporate finance, Underwriting, Security, Public offering, Shelf registration, Stock, Greenshoe

All of the shares in the underwritten public offering are to be sold by Oramed.

Key Points: 
  • All of the shares in the underwritten public offering are to be sold by Oramed.
  • Oramed intends to grant the underwriters a 45-day option to purchase up to an additional 15% of the shares of common stock offered in the public offering at the public offering price, less the underwriting discount.
  • National Securities Corporation, a wholly owned subsidiary of National Holdings Corporation, is acting as the sole book running manager for the offering.
  • The shares of common stock are being offered by Oramed pursuant to its shelf registration statement on Form S-3 (File No.

TELUS announces closing of C$1.5 billion equity offering

Retrieved on: 
Wednesday, February 26, 2020
S&P/TSX 60 Index, Telus, Economy, Initial public offering, Financial markets, Allotment, Greenshoe, Subscription, Option

VANCOUVER, British Columbia, Feb. 26, 2020 (GLOBE NEWSWIRE) -- TELUS Corporation (TELUS or the Company) (TSX-T, NYSE-TU) announced today the closing of its bought deal offering (the Offering) of common shares (the Common Shares) announced on February 19, 2020, including the full exercise of the over-allotment option (the Over-Allotment Option).

Key Points: 
  • VANCOUVER, British Columbia, Feb. 26, 2020 (GLOBE NEWSWIRE) -- TELUS Corporation (TELUS or the Company) (TSX-T, NYSE-TU) announced today the closing of its bought deal offering (the Offering) of common shares (the Common Shares) announced on February 19, 2020, including the full exercise of the over-allotment option (the Over-Allotment Option).
  • Including the exercise of the Over-Allotment Option, the Company sold an aggregate of 28,750,000 Common Shares for total gross proceeds of C$1,495,000,000.
  • Proceeds of the Offering will be used for general corporate purposes including funding growth opportunities, capital expenditures and the reduction of indebtedness.
  • TELUS Health is Canada's largest healthcare IT provider, and TELUS International delivers the most innovative business process solutions to some of the worlds most established brands.

Calian Completes $69 Million Upsized Bought Deal Public Offering

Retrieved on: 
Tuesday, February 25, 2020
Calian, Articles, Greenshoe, Health care, Health professional, Economy of Canada, Economy

OTTAWA, Feb. 25, 2020 (GLOBE NEWSWIRE) -- Calian Group Ltd. (Calian or the Company) (TSX:CGY) is pleased to announce that it has completed its previously announced upsized bought deal offering, under which a total of 1,568,600 common shares of Calian (the "Common Shares") were sold at a price of $44.00 per Common Share for aggregate gross proceeds of $69,018,400, including Common Shares issued pursuant to the exercise in full of the over-allotment option granted to the Underwriters (as defined below) (the "Offering").

Key Points: 
  • OTTAWA, Feb. 25, 2020 (GLOBE NEWSWIRE) -- Calian Group Ltd. (Calian or the Company) (TSX:CGY) is pleased to announce that it has completed its previously announced upsized bought deal offering, under which a total of 1,568,600 common shares of Calian (the "Common Shares") were sold at a price of $44.00 per Common Share for aggregate gross proceeds of $69,018,400, including Common Shares issued pursuant to the exercise in full of the over-allotment option granted to the Underwriters (as defined below) (the "Offering").
  • Calian employs over 3,400 people in its delivery of diverse products and solutions for private sector, government and defence customers in North American and global markets.
  • The Health segment manages a network of more than 1,800 health care professionals delivering primary care and occupational health services to public and private sector clients across Canada.
  • The Information Technology segment supports public- and private-sector customer requirements for subject matter expertise in the delivery of complex IT and cyber security solutions.

TRxADE GROUP, INC. Announces Exercise of Overallotment Option by Underwriters

Retrieved on: 
Monday, February 24, 2020
Initial public offering, Stock market, Greenshoe, Finance, Underwriting, Schiff Hardin, Money, Economy

Trxade Group received gross proceeds of approximately $0.7 million from the sale of common stock from the underwriters exercise of their overallotment option, prior to deducting offering expenses.

Key Points: 
  • Trxade Group received gross proceeds of approximately $0.7 million from the sale of common stock from the underwriters exercise of their overallotment option, prior to deducting offering expenses.
  • Trxade Group intends to use the net proceeds from the offering for working capital and general corporate purposes and possibly to fund acquisitions of other companies, products or technologies.
  • Dawson James Securities, Inc., Dougherty & Company LLC, and ViewTrade Securities, Inc. acted as the underwriters of the offering.
  • Schiff Hardin LLP served as counsel to the underwriters and The Loev Law Firm, PC served as counsel to the Company in connection with the offering.

ADMA Biologics Announces Closing of Full Exercise of Underwriters’ Option to Purchase Additional Shares in Connection with Its Public Offering of Common Stock

Retrieved on: 
Monday, February 24, 2020
Financial economics, Finance, Money, Financial markets, Stock market, Corporate finance, U.S. Securities and Exchange Commission, Prospectus, Shelf registration, Registration statement, Greenshoe, Public offering

The shares were issued pursuant to the full exercise of the underwriters overallotment option in connection with ADMAs previously announced underwritten public offering of 23,500,000 shares of its common stock.

Key Points: 
  • The shares were issued pursuant to the full exercise of the underwriters overallotment option in connection with ADMAs previously announced underwritten public offering of 23,500,000 shares of its common stock.
  • Morgan Stanley and Jefferies LLC acted as joint book-running managers for the offering.
  • The offering was made only by means of a prospectus supplement and accompanying prospectus forming part of a shelf registration statement on Form S-3 (File No.
  • These forward-looking statements include statements about the offering and ADMAs intended use of proceeds generated from the offering.

Document Security Systems, Inc. Prices $4 Million Underwritten Public Offering of Common Stock

Retrieved on: 
Friday, February 21, 2020
Finance, Financial economics, Initial public offering, Stock market, Corporate finance, Financial markets, Underwriting, Subscription, Public offering, Stock, Greenshoe, Red herring prospectus

Heng Fai Ambrose Chan, the Chairman of the Companys Board of Directors, purchased $2 million of shares in the offering.

Key Points: 
  • Heng Fai Ambrose Chan, the Chairman of the Companys Board of Directors, purchased $2 million of shares in the offering.
  • The Company has also granted the underwriters a 45-day option to purchase up to an additional 15% of the number of shares of common stock offered in the public offering to cover over-allotments, if any, at the public offering price, less the underwriting discounts and commissions.
  • The offering is expected to close on or about February 25, 2020, subject to customary closing conditions.
  • This offering is being made pursuant to an effective registration statement on Form S-1 (No.

Independence Realty Trust, Inc. Announces Underwriters’ Exercise of Over-Allotment Option to Purchase Additional Shares

Retrieved on: 
Thursday, February 20, 2020
REIT, Finance, Professional services, Residential Building & Real Estate, Construction & Property, Stock market, Finance, Financial economics, Greenshoe, Money, IRT Flushing Line, Underwriting

Independence Realty Trust, Inc. (NYSE: IRT) (IRT) today announced that the underwriters of its previously announced public offering of 9,000,000 common shares have fully exercised their over-allotment option to purchase an additional 1,350,000 shares at a price of $15.30 per share.

Key Points: 
  • Independence Realty Trust, Inc. (NYSE: IRT) (IRT) today announced that the underwriters of its previously announced public offering of 9,000,000 common shares have fully exercised their over-allotment option to purchase an additional 1,350,000 shares at a price of $15.30 per share.
  • KeyBanc Capital Markets Inc. and BMO Capital Markets Corp. are acting as joint book-running managers and representatives of the underwriters for the offering.
  • Incorporated and Capital One Securities, Inc. are also acting as joint book-running managers for the offering.
  • IRT will enter into a separate forward sale agreement with respect to an additional 1,350,000 shares in connection with the underwriters exercise in full of their option to purchase additional shares.

Twist Bioscience Announces Pricing of Upsized $130.0 Million Public Offering of Common Stock

Retrieved on: 
Thursday, February 20, 2020
Health, Technology, Nanotechnology, Research, Science, Pharmaceutical, Biotechnology, Financial markets, Financial economics, Finance, Initial public offering, Corporate finance, Stock market, Actuarial science, Underwriting, Stock, Public offering, Option, Greenshoe

Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced the pricing of an underwritten public offering of 4,642,857 shares of its common stock at a price to the public of $28.00 per share.

Key Points: 
  • Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced the pricing of an underwritten public offering of 4,642,857 shares of its common stock at a price to the public of $28.00 per share.
  • The gross proceeds of the offering to Twist before deducting the underwriting discount and commissions and estimated offering expenses, and assuming no exercise of the underwriters option to purchase additional shares, are expected to be approximately $130.0 million.
  • Twist has granted the underwriters an option for a period of 30 days to purchase up to an additional 696,428 shares of its common stock at the public offering price, less the underwriting discount and commissions.
  • The offering is expected to close on or about February 24, 2020, subject to the satisfaction of customary closing conditions.